Oracle (ORCL) PT Raised to $142 at CFRA

Argus Upgrades Oracle (ORCL) to Buy

Argus analyst Joseph Bonner upgraded Oracle (NYSE: ORCL) from Hold to Buy with a price target of $145.00.

The analyst comments "Management sees revenue acceleration into FY25. Oracle reported a 16% increase in non-GAAP EPS on 7% revenue growth in fiscal. We are raising Our... More

Oracle (ORCL) PT Raised to $120 at Stifel, 'continue to believe win rates are unlikely to meaningfully change'

(Updated - March 12, 2024 9:55 AM EDT)

Stifel analyst Brad Reback raised the price target on Oracle (NYSE: ORCL) to $120.00 (from $100.00) while maintaining a Hold rating.

The analyst commented: "Oracle delivered results that were in-line with Street estimates, as strength in cloud (largely license) was offset by weakness in services. Given the... More

Oracle (ORCL) PT Raised to $150 at UBS

UBS analyst Karl Keirstead raised the price target on Oracle (NYSE: ORCL) to $150.00 (from $130.00) while maintaining a Buy rating.... More

Oracle (ORCL) PT Raised to $145 at TD Cowen

TD Cowen analyst Derrick Wood raised the price target on Oracle (NYSE: ORCL) to $145.00 (from $130.00) while maintaining a Outperform rating.

The analyst comments "ORCL reported a solid 3Q w/ total rev growth of 7% cc in line w/ guide of 6-8%, incl.... More

Oracle (ORCL) PT Raised to $160 at Mizuho, 'management's FY26 targets increasingly look conservative'

(Updated - March 12, 2024 10:14 AM EDT)

Mizuho analyst Siti Panigrahi raised the price target on Oracle (NYSE: ORCL) to $160.00 (from $140.00) while maintaining a Buy rating.

The analyst commented: "Oracle's FQ3 results reflect the bounceback in OCI momentum as the company delivered... More

Inflation data ahead, Oracle earnings - what's moving markets

Investing.com -- Markets are awaiting fresh U.S. inflation figures that could factor into how the Federal Reserve approaches potential interest rate cuts this year. Stock futures on Wall Street inch broadly higher ahead of the data. Oracle (NYSE: ORCL) shares surge in extended hours trading after the tech group posts an AI-driven earnings beat, while the price of Bitcoin remains just under a recent record high.

1. Inflation data ahead

U.S. inflation data for February is set to take center stage on... More

Oracle (ORCL) PT Raised to $145 at Evercore ISI, 'Outlook Less Cloudy'

Evercore ISI analyst Kirk Materne raised the price target on Oracle (NYSE: ORCL) to $145.00 (from $130.00) while maintaining a Outperform rating.

The analyst comments "Bottom line: Oracle shares are up nicely in the after-market as OCI revenue growth of 52% in c/c was in line with our expectations and importantly, F4Q guidance infers OCI growth of ~40% against a very difficult compare. The other highlight was the strength in RPO, which grew 41% in c/c excl. Cerner to $80bn and cRPO growth of ~15%. Notably, OCI revenue grew $175mn sequentially vs. $100mn last quarter.... More

Oracle (ORCL) PT Raised to $150 at Jefferies, 'F3Q: Base Hit, One Runner On'

Jefferies analyst Brent Thill raised the price target on Oracle (NYSE: ORCL) to $150.00 (from $145.00) while maintaining a Buy rating.

The analyst comments "ORCL made contact in F3Q after a disappointing F1H led by better-than-expected OCI results and 29% backlog growth. While... More

Guggenheim Reviews 'Best Idea' Oracle (ORCL) Earnings

Guggenheim analyst John DiFucci reiterated a Buy rating and $150.00 price target on Oracle (NYSE: ORCL)

The analyst comments "ORCL surprised to the upside in OCI, and although Cloud ex. Cerner was at the low end of guidance, it was probably at least what the buy side was looking for. ORCLs results were a stark contrast to the recent decelerating business momentum of most Software names (as measured by a 2-year stack of New ARR growth see Exhibit 1). New ARR for organic Cloud accelerated to about 28% growth, and New ARR for IaaS... More

Oracle (ORCL) PT Raised to $144 at BofA Securities, 'growth and margin still lagging targets'

(Updated - March 12, 2024 4:57 AM EDT)

BofA Securities analyst Kash Rangan raised the price target on Oracle (NYSE: ORCL) to $144.00 (from $122.00) while maintaining a Neutral rating.

The analyst comments "Oracle reported solid cloud growth metrics this quarter relative to low expectations, following two... More

William Blair Upgrades Oracle (ORCL) to Outperform, 'Sustained Growth Acceleration'

(Updated - March 12, 2024 5:59 AM EDT)

William Blair analyst Sebastien Naji upgraded Oracle (NYSE: ORCL) from Market Perform to Outperform.

The analyst comments "What You Need to Know: Oracle reported a solid print, with roughly in-line results for the third quarter, though... More

Oracle (ORCL) PT Raised to $159 at Bernstein, 'Solid quarter, positive outlook'

Bernstein analyst Mark Moerdler raised the price target on Oracle (NYSE: ORCL) to $159.00 (from $147.00) while maintaining a Outperform rating.

The analyst comments "Oracle delivered a good quarter, coming in line with expectations on total revenue, driven by a beat in cloud and software. The company also delivered a nice operating margin improvement. More importantly, Oracle provided a solid... More

Oracle (ORCL) PT Raised to $105 at JPMorgan

(Updated - March 12, 2024 4:23 AM EDT)

JPMorgan analyst Mark Murphy raised the price target on Oracle (NYSE: ORCL) to $105.00 (from $100.00) while maintaining a Neutral rating.

The analyst comments "We have a Neutral rating on Oracle. We think the presence of a resilient,... More

Oracle (ORCL) PT Raised to $142 at BMO Capital

(Updated - March 12, 2024 4:22 AM EDT)

BMO Capital analyst Keith Bachman raised the price target on Oracle (NYSE: ORCL) to $142.00 (from $126.00) while maintaining a Market Perform rating.

The analyst comments "Very strong RPO bookings of 29% y/y and 23% q/q will more than offset... More

Oracle (ORCL) PT Raised to $150 at Wolfe Research, 'Power Over RPO, Is Power Over All'

(Updated - March 12, 2024 4:23 AM EDT)

Wolfe Research analyst Alex Zukin raised the price target on Oracle (NYSE: ORCL) to $150.00 (from $130.00) while maintaining a Outperform rating.

The analyst comments "Coming into a quarter where there was tremendous doubt around the demand for Oracle Cloud, the company posted an RPO number that should silence the non-believers. RPO grew 29% Y/Y, and 23% sequentially, but to truly understand the magnitude, the sequential dollar add of... More

Oracle (ORCL) PT Raised to $115 at Morgan Stanley, 'outstanding uncertainties surrounding installed base'

(Updated - March 12, 2024 4:24 AM EDT)

Morgan Stanley analyst Keith Weiss raised the price target on Oracle (NYSE: ORCL) to $115.00 (from $106.00) while maintaining a Equalweight rating.

The analyst comments " Despite potential opportunities surrounding OCI, existing database customers and cloud-based ERP applications,... More

Oracle (ORCL) PT Raised to $130 at Goldman Sachs, 'remains to be seen if Oracle can execute on its ramping backlog'

(Updated - March 12, 2024 4:25 AM EDT)

Goldman Sachs analyst Kash Rangan raised the price target on Oracle (NYSE: ORCL) to $130.00 (from $115.00) while maintaining a Neutral rating.

The analyst comments "

Oracle is indicated +14% AH on a solid F3Q print that saw revenue in line with Consensus, IaaS growth of +49% and EPS of $1.41 (+2% above Consensus). The F3Q stand outs... More

Oracle (ORCL) PT Raised to $147 at Barclays, 'RPO Strength And Capex Ramp Point To Better Times Ahead'

(Updated - March 12, 2024 4:26 AM EDT)

Barclays analyst Raimo Lenschow raised the price target on Oracle (NYSE: ORCL) to $147.00 (from $140.00) while maintaining a Overweight rating.

The analyst comments "Q3 in itself was a solid quarter for ORCL with slightly better application and... More

Popular stocks with increasing volume: PLTR BA NIO RIVN TSM SOFI COIN ORCL HOOD INTC C PFE

Popular stocks with increasing volume: PLTR BA NIO RIVN TSM SOFI COIN ORCL HOOD INTC C PFE

Stocks expected to have increasing option volume: ORCL ADM CASY MTN KSS ACAD ASAN NVDA AMD ARM SMCI IRBT ONON

Stocks expected to have increasing option volume: ORCL ADM CASY MTN KSS ACAD ASAN NVDA AMD ARM SMCI IRBT ONON

After-hours movers: Oracle surges, Acadia Pharma slumps

After-Hours Stock Movers:

Oracle (NYSE: ORCL) stock rose 10% after it reported revenue that matched consensus expectations and a slight beat on EPS last quarter.

Acadia Pharma (NASDAQ: ACAD) declined 15% after announcing top-line results from the Phase 3... More

Oracle reports Q3 results beat; touts new business wins amid AI-fueled demand

Investing.com -- Oracle reported Monday fiscal third-quarter results that topped Wall Street estimates and software company touted large new business wins, driven by artificial-intelligence demand for cloud infrastructure.

Oracle Corporation (NYSE: ORCL) was up more than 6% in afterhours following the... More

Oracle tops quarterly profit estimates on AI demand, shares surge

By Harshita Mary Varghese

(Reuters) -Oracle said on Monday it is set to make a joint announcement with chip-giant Nvidia, and it beat estimates for quarterly profit, riding on the generative AI demand boom, sending shares up nearly 14% in extended trading.

The late-day rally in Oracle's shares added more than $40 billion to its stock market value.

The 46-year-old database giant has been trying to reinvent itself as a cloud-computing provider by offering services cheaper than... More

Oracle (ORCL) Tops Q3 EPS by 3c

Oracle (NYSE: ORCL) reported Q3 EPS of $1.41, $0.03 better than the analyst estimate of $1.38. Revenue for the quarter came in at $13.3 billion versus the consensus estimate of $13.29 billion.

For earnings history and earnings-related data on Oracle (ORCL) click here.

Oracle (ORCL) call put ratio 1.7 calls to 1 put into quarter results

Oracle (NYSE: ORCL) March call option implied volatility is at 106, March weekly is at 42; compared to its 52-week range of 18 to 47 into the expected release of quarter results today after the bell.

Oracle (ORCL) March 113 straddle into quarter results

Oracle (NYSE: ORCL) March 113 straddle priced for a move of 9% into the expected release of quarter results today after the bell.

Stocks expected to have increasing option volume: ORCL NVDA AMD ARM SMCI

Stocks expected to have increasing option volume: ORCL NVDA AMD ARM SMCI

Oracle (ORCL) call put ratio 2.4 calls to 1 put into quarter results and outlook

Oracle (NYSE: ORCL) March call option implied volatility is at 76, March weekly is at 57; compared to its 52-week range of 18 to 47 into the expected release of quarter results after the bell on March 11.

Oracle (ORCL) March 114 straddle into quarter results

Oracle (NYSE: ORCL) March 114 straddle priced for a move of 8.5% into the expected release of quarter results after the bell on March 11.